Nuvalent to Participate in the UBS 2025 Virtual Oncology Day | NUVL Stock News
I'm PortAI, I can summarize articles.
Nuvalent, Inc. (Nasdaq: NUVL) announced that CEO James Porter and CFO Alexandra Balcom will participate in a fireside chat at the UBS 2025 Virtual Oncology Day on October 1, 2025, at 3:30 p.m. ET. A live webcast will be available on the company's website and archived for 30 days. Nuvalent focuses on developing targeted therapies for cancer, with a pipeline addressing various lung cancer types.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments